Omegapress 0.2 Mg 30 Tablets

Omegapress 0.2 Mg 30 Tablets

Description:

Omegapress 0.2 mg 30 tablets is a prescription medicine containing desmopressin acetate, a synthetic analogue of the natural antidiuretic hormone (ADH). It is primarily used to reduce excessive urine production and control frequent urination, especially at night. By acting on specific receptors in the kidneys, Omegapress helps the body retain water, decrease urine volume, and improve symptoms related to nocturnal enuresis and diabetes insipidus. This product is intended for use under medical supervision as part of a comprehensive health and disease prevention plan.

Indications:

• Treatment and management of central diabetes insipidus (a condition characterized by excessive thirst and large volumes of dilute urine due to ADH deficiency).
• Management of primary nocturnal enuresis (bedwetting) in patients where organic causes have been excluded and non-pharmacological measures are insufficient (as directed by a physician).
• Control of excessive nocturnal urine production (nocturnal polyuria) to reduce nighttime urination episodes, as prescribed by a healthcare professional.
• May be used as part of a hemostatic regimen in certain bleeding disorders such as mild hemophilia A or type 1 von Willebrand disease (only under specialist supervision and according to local approved indications).

Active Ingredients / Key Components:

• Desmopressin acetate – 0.2 mg per tablet (active antidiuretic and hemostatic agent).
• Excipients: Full list of inactive ingredients (tablet core and coating components, such as fillers, binders, disintegrants, and colorants) is not available in the provided information. Please refer to the official package insert for complete excipient details.

Dosage & Administration / How to Use:

• Dosage must always be individualized and determined by the treating physician based on the indication, age, kidney function, and patient response.
• For nocturnal enuresis / nocturnal polyuria (typical oral dosing guidance – for reference only, follow your doctor’s instructions):
  • Common starting dose: 0.2 mg (one tablet) taken orally at bedtime.
  • The dose may be adjusted by the physician, usually within the range of 0.2–0.4 mg at bedtime, depending on clinical response and tolerability.
• For central diabetes insipidus (oral therapy – under specialist supervision):
  • Dose and frequency (often 2–3 times daily) are tailored by the physician according to urine output, thirst, and serum sodium levels.
• Administration instructions:
  • Swallow the tablet with a small amount of water.
  • Can be taken with or without food, but try to take it at the same time each day for consistent effect.
  • Strict fluid restriction is usually required from 1 hour before taking the tablet until at least 8 hours after dosing, as advised by your doctor, to reduce the risk of water retention and hyponatremia.
• If you miss a dose, take it as soon as you remember unless it is close to the time for the next dose. Do not double the dose to make up for a missed one.
• Do not stop or change the dose without consulting your doctor.

Clinical Benefits:

• Reduces excessive urine production by selectively stimulating V2 receptors in the kidney collecting ducts, enhancing water reabsorption.
• Helps control nocturnal enuresis and frequent nighttime urination, supporting better, uninterrupted sleep and improved quality of life.
• Assists in maintaining fluid balance in patients with central diabetes insipidus, decreasing extreme thirst (polydipsia) and excessive urination (polyuria).
• Provides hemostatic support in selected bleeding disorders by increasing plasma levels of factor VIII and von Willebrand factor (when used under specialist guidance).

Warnings & Contraindications:

• Use only under medical supervision. Incorrect use can cause serious water retention and low blood sodium (hyponatremia), which may be life-threatening.
• Contraindicated in patients with known hypersensitivity to desmopressin acetate or any component of the formulation.
• Contraindicated in conditions associated with fluid overload or predisposition to hyponatremia, such as moderate to severe renal impairment, syndrome of inappropriate antidiuretic hormone secretion (SIADH), uncontrolled heart failure, or habitual/polydipsic excessive fluid intake.
• Not recommended in patients with hyponatremia or a history of hyponatremia.
• Use with extreme caution in elderly patients, children, and those at risk of electrolyte imbalance; regular monitoring of serum sodium and fluid status is advised.
• Consult your doctor before use if pregnant or planning pregnancy. Desmopressin should be used during pregnancy only if clearly needed and under medical supervision.
• If breastfeeding, consult your healthcare provider before use. Your doctor will weigh the potential benefits and risks.
• Inform your doctor if you have any of the following: kidney disease, heart disease, high blood pressure, cystic fibrosis, history of seizures, or conditions requiring strict fluid management.
• Caution when used with medications that increase the risk of water retention or hyponatremia (e.g., certain antidepressants such as SSRIs or tricyclics, NSAIDs, carbamazepine, chlorpropamide). Always inform your doctor of all medicines you are taking.
• Limit or avoid alcohol while using this medicine, as alcohol can reduce the antidiuretic effect and may affect fluid balance.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical evaluation and prescription.
• Keep out of reach of children.

Side Effects:

• Common side effects may include headache, nausea, mild stomach discomfort, nasal congestion (less common with tablets than nasal forms), and slight weight gain due to fluid retention.
• Serious side effects (seek immediate medical attention): signs of hyponatremia such as severe or persistent headache, confusion, drowsiness, unusual tiredness, irritability, nausea and vomiting, sudden weight gain, muscle cramps, seizures, or loss of consciousness.
• Allergic reactions (rare): rash, itching, swelling of the face, lips, tongue, or throat, severe dizziness, or difficulty breathing. Stop the medicine and seek urgent medical care if these occur.
• If any side effects worsen or you notice any other unusual symptoms, contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Do not store above the temperature specified on the package insert (exact storage temperature is not available in the provided information; refer to the original pack).

Specifications:

• Product form: Tablets.
• Strength: 0.2 mg desmopressin acetate per tablet.
• Pack size: 30 tablets per pack.
• Intended use: Prescription medicine for the management of central diabetes insipidus, nocturnal enuresis, and related conditions as directed by a physician.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.